Literature DB >> 2262358

Patterns of failure following curative resection of gastric carcinoma.

J Landry1, J E Tepper, W C Wood, E O Moulton, F Koerner, J Sullinger.   

Abstract

To identify patterns of failure following curative resection of gastric carcinoma, the records of 130 patients undergoing resection with curative intent at the Massachusetts General Hospital were reviewed. The total local-regional failure rate was 38% (49/130 patients), with 21 patients having local-regional failure alone and 28 patients having local-regional failure and distant metastases. The incidence of local failure rose with the more advanced stages of disease. Tumors staged B2, B3, C2, and C3 had local-regional failure rates in excess of 35%. This group of patients might benefit from adjuvant radiation therapy to the tumor bed and regional lymphatics. Local-regional failure rate was highest in the anastomosis or stump 33/130 (25%), followed by the stomach bed 27/130 (21%). The overall incidence of distant metastases was 52% (67/130 patients) and rose in the more advanced disease stages. Tumors staged B2, B3, C2, and C3 had rates of distant metastases greater than 50%. Sixty-one patients (77%) had failure in the abdomen (liver, peritoneal surface, adrenal, kidney, and spleen, but excluding tumor bed, anastomosis, or regional nodes). Patients with Stage B2, B3, C2, and C3 tumors had total abdominal failure rates greater than 40%. The highest failure rates in the liver were in Stages B3 and C3, in which the subsequent development of liver metastasis was 40% and 47%, respectively. Peritoneal seeding occurred in 30/130 (23%) of patients and was highest in Stages C2 and C3, with rates of 27% and 41%, respectively.

Entities:  

Mesh:

Year:  1990        PMID: 2262358     DOI: 10.1016/0360-3016(90)90344-j

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  64 in total

1.  Clinical outcomes according to primary treatment in gastric cancer patients with peritoneal seeding.

Authors:  Jung Min Bae; Kyoung Joon Yeo; Se Won Kim; Sang Woon Kim; Sun Kyo Song
Journal:  J Gastric Cancer       Date:  2011-09-29       Impact factor: 3.720

2.  When is curative gastrectomy justified for gastric cancer with positive peritoneal lavage cytology but negative macroscopic peritoneal implant?

Authors:  Isao Miyashiro; Ko Takachi; Yuichiro Doki; Osamu Ishikawa; Hiroaki Ohigashi; Kohei Murata; Yo Sasaki; Shingi Imaoka; Akihiko Nakaizumi; Akemi Takenaka; Hiroshi Furukawa; Masahiro Hiratsuka
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

3.  Accomplishments in 2007 in the management of localized gastric cancer.

Authors:  Cornelis J H van de Velde; Al B Benson
Journal:  Gastrointest Cancer Res       Date:  2008-05

4.  Continuous low-dose irradiation by I-125 seeds induces apoptosis of gastric cancer cells regardless of histological origin.

Authors:  Kaoru Takabayashi; Kazuhiro Kashiwagi; Tetsuya Kawata; Toshiro Sato; Katsuyoshi Matsuoka; Tadakazu Hisamatsu; Hiromasa Takaishi; Toshifumi Hibi; Haruhiko Ogata; Naohisa Yahagi; Yuko Kitagawa; Naoyuki Shigematsu; Takanori Kanai
Journal:  Cancer Biol Ther       Date:  2013-10-22       Impact factor: 4.742

5.  Image-guided intensity-modulated radiotherapy for patients with locally advanced gastric cancer: a clinical feasibility study.

Authors:  Harun Badakhshi; Arne Gruen; Reinhold Graf; Dirk Boehmer; Volker Budach
Journal:  Gastric Cancer       Date:  2013-10-11       Impact factor: 7.370

6.  Influence of interfraction motion on margins for radiotherapy of gastric cancer.

Authors:  A Namysł-Kaletka; J Wydmanski; A Tukiendorf; D Bodusz; W Leszczynski; R Kawczynski; K Grabinska; P Polanowski
Journal:  Br J Radiol       Date:  2015-02-10       Impact factor: 3.039

Review 7.  Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: is radiotherapy necessary after D2-dissection?

Authors:  Jee Suk Chang; Woong Sub Koom; Youngin Lee; Hong In Yoon; Hyung Sik Lee
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

8.  Stage-specific survival differences associated with postoperative radiotherapy for gastrointestinal cancers.

Authors:  John S Moody; Stephen M Sawrie; Kevin R Kozak; John P Plastaras; George Howard; James A Bonner
Journal:  J Gastrointest Cancer       Date:  2009-03-18

9.  Treatment of adenocarcinoma of the stomach with resection, intraoperative radiotherapy, and adjuvant external beam radiation: a phase II study from Radiation Therapy Oncology Group 85-04.

Authors:  V N Avizonis; J Buzydlowski; R Lanciano; J C Owens; R D Noyes; G E Hanks
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

10.  Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy.

Authors:  Valerie K Reed; Sunil Krishnan; Paul F Mansfield; Priya R Bhosale; Michelle Kim; Prajnan Das; Nora A Janjan; Marc E Delclos; Andrew M Lowy; Barry W Feig; Peter W T Pisters; Jaffer A Ajani; Christopher H Crane
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.